ES8602799A1 - Un procedimiento para preparar 6-metilsulfoxido-espiro-(croman-4,4'-imidazolidin)-2',5'-diona - Google Patents
Un procedimiento para preparar 6-metilsulfoxido-espiro-(croman-4,4'-imidazolidin)-2',5'-dionaInfo
- Publication number
- ES8602799A1 ES8602799A1 ES538137A ES538137A ES8602799A1 ES 8602799 A1 ES8602799 A1 ES 8602799A1 ES 538137 A ES538137 A ES 538137A ES 538137 A ES538137 A ES 538137A ES 8602799 A1 ES8602799 A1 ES 8602799A1
- Authority
- ES
- Spain
- Prior art keywords
- hydantoin
- therapeutic agents
- chromanimidazolidine
- methythio
- methylsulfinyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
Abstract
PROCEDIMIENTO DE OBTENCION DEL COMPUESTO II.CONSISTENTE EN SOMETER A OXIDACION CON PEROXIDO DE HIDROGENO Y/O METAPERYODATO POTASICO EN UN DISOLVENTE APROPIADO A LA 6-METILTIO-ESPIRO-(CROMAN -4,4-IMIDAZOLIDIN)-2, 5-DIONA DE FORMULA I PARA OBTENER EL COMPUESTO DE FORMULA II.UTIL EN EL TRATAMIENTO DE COMPLICACIONES RESULTANTES DE LA DIABETES MELLITUS, TALES COMO CATARATAS, NEUROPATIAS, RETINOPATIAS Y NEFROPATIAS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/368,629 US4464385A (en) | 1982-04-15 | 1982-04-15 | Treatment of diabetic complications with hydantoins |
Publications (2)
Publication Number | Publication Date |
---|---|
ES8602799A1 true ES8602799A1 (es) | 1985-12-01 |
ES538137A0 ES538137A0 (es) | 1985-12-01 |
Family
ID=23452055
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES521445A Expired ES8500951A1 (es) | 1982-04-15 | 1983-04-14 | Un procedimiento para preparar 6-metil-tio-espiro-ckroman-4,4' imidazolin-2',5'-diona. |
ES538137A Granted ES538137A0 (es) | 1982-04-15 | 1984-11-30 | Un procedimiento para preparar 6-metilsulfoxido-espiro-(croman-4,4'-imidazolidin)-2',5'-diona |
ES538138A Expired ES8507552A1 (es) | 1982-04-15 | 1984-11-30 | Un procedimiento para preparar 6-metilsulfonil-espiro-(croman-4,4'-imidazolidin)-2',5'-diona |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES521445A Expired ES8500951A1 (es) | 1982-04-15 | 1983-04-14 | Un procedimiento para preparar 6-metil-tio-espiro-ckroman-4,4' imidazolin-2',5'-diona. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES538138A Expired ES8507552A1 (es) | 1982-04-15 | 1984-11-30 | Un procedimiento para preparar 6-metilsulfonil-espiro-(croman-4,4'-imidazolidin)-2',5'-diona |
Country Status (15)
Country | Link |
---|---|
US (1) | US4464385A (es) |
EP (1) | EP0092386B1 (es) |
KR (1) | KR890000156B1 (es) |
AT (1) | ATE36333T1 (es) |
AU (1) | AU552937B2 (es) |
CA (1) | CA1201715A (es) |
DE (1) | DE3377650D1 (es) |
ES (3) | ES8500951A1 (es) |
GR (1) | GR78183B (es) |
IE (1) | IE55227B1 (es) |
IL (1) | IL68422A0 (es) |
NZ (1) | NZ203875A (es) |
PT (1) | PT76551B (es) |
WO (1) | WO1983003542A1 (es) |
ZA (1) | ZA832491B (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4540700A (en) * | 1982-04-15 | 1985-09-10 | Alcon Laboratories, Inc. | Treatment of diabetic complications with certain spiro-imidazolidine-diones |
JPH0772190B2 (ja) * | 1985-02-26 | 1995-08-02 | エーザイ株式会社 | ヒダントイン誘導体 |
JPS61200991A (ja) * | 1985-03-04 | 1986-09-05 | Sanwa Kagaku Kenkyusho:Kk | スピロ―3―ヘテロアゾリジン化合物、その製法及びそれを有効成分とする糖尿病合併症の予防及び治療剤 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2716648A (en) * | 1955-08-30 | Hydantoin derivatives | ||
US2683718A (en) * | 1952-01-11 | 1954-07-13 | Searle & Co | Spiro-[xanthene-9, 4'-imidazolidine]-2, 5-dione |
US3349124A (en) * | 1957-05-20 | 1967-10-24 | Pfizer & Co C | Oral antidiabetic agent |
DE1135915B (de) * | 1961-06-29 | 1962-09-06 | Asta Werke Ag Chem Fab | Verfahren zur Herstellung neuer, antikonvulsiv wirksamer Spirohydantoine |
US3532744A (en) * | 1967-07-28 | 1970-10-06 | American Home Prod | 1- and 2-amino substituted indane and tetralene carboxylic acids |
US3821383A (en) * | 1972-07-10 | 1974-06-28 | Ayerst Mckenna & Harrison | Compositions for and a method of treating diabetic complications |
US4209630A (en) * | 1976-10-18 | 1980-06-24 | Pfizer Inc. | Hydantoin derivatives as therapeutic agents |
US4117230A (en) * | 1976-10-18 | 1978-09-26 | Pfizer Inc. | Hydantoin derivatives as therapeutic agents |
US4147795A (en) * | 1977-02-11 | 1979-04-03 | Pfizer Inc. | Hydantoin derivatives as therapeutic agents |
US4130714A (en) * | 1977-05-23 | 1978-12-19 | Pfizer Inc. | Hydantoin therapeutic agents |
US4127665A (en) * | 1978-01-18 | 1978-11-28 | Pfizer Inc. | Thienohydantoin derivatives |
US4147797A (en) * | 1978-08-11 | 1979-04-03 | Pfizer Inc. | Spiro-furanohydantoin derivatives |
US4200642A (en) * | 1978-08-21 | 1980-04-29 | Pfizer Inc. | Spiro-oxazolidindiones |
US4181728A (en) * | 1978-11-16 | 1980-01-01 | Pfizer Inc. | Spiro-polycyclicimidazolidinedione derivatives |
US4327107A (en) * | 1979-02-06 | 1982-04-27 | A. H. Robins Company, Inc. | Method useful in the treatment of sugar cataracts using 4-substituted-2-iminoimidazolidine compounds |
US4181729A (en) * | 1979-03-21 | 1980-01-01 | Pfizer Inc. | Phenyl or phenoxy substituted spiro-imidazolidinedione derivatives |
US4307108A (en) * | 1979-12-26 | 1981-12-22 | Pfizer Inc. | Method for lowering sorbitol levels using spiro-imides |
JPS5899480A (ja) * | 1981-12-04 | 1983-06-13 | Senjiyu Seiyaku Kk | 新規クロマン誘導体 |
-
1982
- 1982-04-15 US US06/368,629 patent/US4464385A/en not_active Expired - Fee Related
-
1983
- 1983-04-08 ZA ZA832491A patent/ZA832491B/xx unknown
- 1983-04-08 AU AU13258/83A patent/AU552937B2/en not_active Ceased
- 1983-04-11 WO PCT/US1983/000545 patent/WO1983003542A1/en unknown
- 1983-04-12 IE IE836/83A patent/IE55227B1/en not_active IP Right Cessation
- 1983-04-13 NZ NZ203875A patent/NZ203875A/en unknown
- 1983-04-13 GR GR71073A patent/GR78183B/el unknown
- 1983-04-14 PT PT76551A patent/PT76551B/pt not_active IP Right Cessation
- 1983-04-14 DE DE8383302112T patent/DE3377650D1/de not_active Expired
- 1983-04-14 EP EP83302112A patent/EP0092386B1/en not_active Expired
- 1983-04-14 KR KR8301570A patent/KR890000156B1/ko not_active IP Right Cessation
- 1983-04-14 ES ES521445A patent/ES8500951A1/es not_active Expired
- 1983-04-14 CA CA000425865A patent/CA1201715A/en not_active Expired
- 1983-04-14 AT AT83302112T patent/ATE36333T1/de not_active IP Right Cessation
- 1983-04-15 IL IL68422A patent/IL68422A0/xx not_active IP Right Cessation
-
1984
- 1984-11-30 ES ES538137A patent/ES538137A0/es active Granted
- 1984-11-30 ES ES538138A patent/ES8507552A1/es not_active Expired
Also Published As
Publication number | Publication date |
---|---|
CA1201715A (en) | 1986-03-11 |
GR78183B (es) | 1984-09-26 |
NZ203875A (en) | 1985-12-13 |
ES538138A0 (es) | 1985-09-01 |
ES538137A0 (es) | 1985-12-01 |
ATE36333T1 (de) | 1988-08-15 |
PT76551A (en) | 1983-05-01 |
AU1325883A (en) | 1983-10-20 |
ZA832491B (en) | 1983-12-28 |
PT76551B (en) | 1986-01-21 |
AU552937B2 (en) | 1986-06-26 |
ES8507552A1 (es) | 1985-09-01 |
IL68422A0 (en) | 1983-07-31 |
ES521445A0 (es) | 1984-11-01 |
DE3377650D1 (en) | 1988-09-15 |
IE55227B1 (en) | 1990-07-04 |
EP0092386B1 (en) | 1988-08-10 |
EP0092386A3 (en) | 1985-03-06 |
ES8500951A1 (es) | 1984-11-01 |
KR840004431A (ko) | 1984-10-15 |
WO1983003542A1 (en) | 1983-10-27 |
EP0092386A2 (en) | 1983-10-26 |
KR890000156B1 (en) | 1989-03-08 |
IE830836L (en) | 1983-10-15 |
US4464385A (en) | 1984-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS5791915A (en) | Novel lipid composition useful for dietetics, resuscitation and treatment | |
DE3377263D1 (en) | Skin treatment composition | |
AU566011B2 (en) | Leather treatment composition | |
AU553269B2 (en) | 2,3-diaryl-5-halo thiophenes | |
PH24723A (en) | Device and composition for treatment of the gums | |
ES8500951A1 (es) | Un procedimiento para preparar 6-metil-tio-espiro-ckroman-4,4' imidazolin-2',5'-diona. | |
DE3462688D1 (en) | 1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane useful in combating diseases | |
GB2124488B (en) | Agent for the treatment of wounds | |
DE3272384D1 (en) | Medicinal composition for the treatment of certain neuroviroses | |
HK44597A (en) | Use of chlormethiazole in the manufacture of a medicament for the prevention and/or treatment of neurodegeneration | |
ZA83662B (en) | Skin treatment composition | |
GB2132505B (en) | Treatment of town's refuse | |
GB2122500B (en) | Device for combined therapeutic and stimulative treatment of the gums | |
EP0278715A3 (en) | Use of human gamma interferon for treatment of basal cell carcinoma | |
HUT37030A (en) | Therapeutic auxiliary device for the treatment of traumatological patients, first of all with lower limb fraction | |
ZW21283A1 (en) | The treatment of ferromanganese | |
ZA837183B (en) | The treatment of ferromanganese | |
AU6761281A (en) | Pre-harvest treatment | |
AU4441479A (en) | Aversion therapy treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD1A | Patent lapsed |
Effective date: 20000601 |